Safety, Tolerability, and Pharmacodynamic Assessment of ANK-700, a Novel Liver-Targeted Therapy to Induce Immunological Tolerance to Myelin Antigens in Relapsing-Remitting Multiple Sclerosis

ANK-700 - Anokion, BMS

https://journals.sagepub.com/doi/epub/10.1177/13524585241269221

Benjamin M. Greenberg1; Jeffrey Cohen2; Amanda Piquet3; Aimee Borazanci4; Derrick Robertson5; Jenny Feng6; Jessica Spivey7; Jack Tseng7; Stephanie Morgan7; Tom Thornley7; Stephen Villano7; Sergey A. Isarov7; Kristie Grebe7

Jul 8, 2024